NCT06700915

A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Ultimate International, Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.

Conditions

• Metabolism Disorder
• Nutraceutical

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Diaberine	Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
DIETARY_SUPPLEMENT	Placebo Capsule	Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.

Timeline

• Start date: 2024-10-03
• Primary completion: 2025-05-01
• Completion: 2025-05-01
• First posted: 2024-11-22
• Last updated: 2024-12-13

Locations

1 site across 1 country: United States